Faculty

Research

Systems

Infrastructure

Patient & Public Awareness

Working with Industry

Research Databases

About Us

News: Cancer drug can treat blindness finds NIHR HTA funded research

Title

Cancer drug can treat blindness finds NIHR HTA funded research 

News Title

Cancer drug can treat blindness finds NIHR HTA funded research 

News Content

A cheap cancer drug is just as effective and safe in treating a common cause of loss of vision as an expensive alternative, finds research funded by the NIHR Health Technology Assessment (HTA) Programme.

The two year study, which published its results in The Lancet, compared anti-cancer drug Avastin (bevacizumab) with Lucentis (ranibizumab), the drug more commonly used for treating wet age-related macular degeneration (wet AMD).

News Link

Read more 

News Date

25/07/2013 

Expires

25/09/2013 

Date Created

 

Date Modified

 
Attachments
Created at 25/07/2013 11:39  by Craig Biggs 
Last modified at 25/07/2013 11:39  by Craig Biggs